Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Norton

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Schizophrenia Research|October 25, 2008
Visual and cognitive processing of face information in schizophrenia: detection, discrimination and working memoryYue Chen, Daniel Norton, Ryan McBain, et al.
Frontiers in Psychology|July 13, 2013
Deficient biological motion perception in schizophrenia: results from a motion noise paradigmJejoong Kim, Daniel Norton, Ryan McBain, et al.
Biological Psychiatry|March 10, 2009
Association of impaired facial affect recognition with basic facial and visual processing deficits in schizophreniaDaniel Norton, Ryan McBain, Daphne J Holt, et al.
Advanced Healthcare Materials|September 14, 2013
Rapid and extensive collapse from electrically responsive macroporous hydrogelsStephen Kennedy, Sidi Bencherif, Daniel Norton, et al.
Journal of Environmental Management|April 25, 2021
A discrete choice experiment exploring farmer preferences for insurance against extreme weather eventsEdel Doherty, Sinead Mellett, Daniel Norton, et al.
Drug and Chemical Toxicology|December 10, 2009
A subchronic murine intravenous pharmacokinetic and toxicity study of Hematide™, a PEGylated peptidic erythropoiesis-stimulating agentKathryn W Woodburn, Qing Fan, Peter J Schatz, et al.
European Journal of Medicinal Chemistry|October 18, 2016
Synthesis and pre-clinical studies of new amino-acid ester thiazolide prodrugsAndrew V Stachulski, Karl Swift, Mark Cooper, et al.
Basic & Clinical Pharmacology & Toxicology|January 16, 2009
Chronic pharmacological and safety evaluation of Hematide, a PEGylated peptidic erythropoiesis-stimulating agent, in rodentsKathryn W Woodburn, Susan D Wilson, Kei-Lai Fong, et al.
Haematologica|June 4, 2008
Chronic preclinical safety evaluation of Hematide, a pegylated peptidic erythropoiesis stimulating agent in monkeysKathryn W Woodburn, Susan D Wilson, Kei-Lai Fong, et al.
Drug and Chemical Toxicology|March 12, 2008
Preclinical safety and pharmacology of Hematide, a peptidic erythropoiesis stimulating agent (ESA), in rats and monkeysKathryn W Woodburn, Peter J Schatz, Kei-Lai Fong, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Schizophrenia Research|October 25, 2008
Visual and cognitive processing of face information in schizophrenia: detection, discrimination and working memoryYue Chen, Daniel Norton, Ryan McBain, et al.
Frontiers in Psychology|July 13, 2013
Deficient biological motion perception in schizophrenia: results from a motion noise paradigmJejoong Kim, Daniel Norton, Ryan McBain, et al.
Biological Psychiatry|March 10, 2009
Association of impaired facial affect recognition with basic facial and visual processing deficits in schizophreniaDaniel Norton, Ryan McBain, Daphne J Holt, et al.
Advanced Healthcare Materials|September 14, 2013
Rapid and extensive collapse from electrically responsive macroporous hydrogelsStephen Kennedy, Sidi Bencherif, Daniel Norton, et al.
Journal of Environmental Management|April 25, 2021
A discrete choice experiment exploring farmer preferences for insurance against extreme weather eventsEdel Doherty, Sinead Mellett, Daniel Norton, et al.
Drug and Chemical Toxicology|December 10, 2009
A subchronic murine intravenous pharmacokinetic and toxicity study of Hematide™, a PEGylated peptidic erythropoiesis-stimulating agentKathryn W Woodburn, Qing Fan, Peter J Schatz, et al.
European Journal of Medicinal Chemistry|October 18, 2016
Synthesis and pre-clinical studies of new amino-acid ester thiazolide prodrugsAndrew V Stachulski, Karl Swift, Mark Cooper, et al.
Basic & Clinical Pharmacology & Toxicology|January 16, 2009
Chronic pharmacological and safety evaluation of Hematide, a PEGylated peptidic erythropoiesis-stimulating agent, in rodentsKathryn W Woodburn, Susan D Wilson, Kei-Lai Fong, et al.
Haematologica|June 4, 2008
Chronic preclinical safety evaluation of Hematide, a pegylated peptidic erythropoiesis stimulating agent in monkeysKathryn W Woodburn, Susan D Wilson, Kei-Lai Fong, et al.
Drug and Chemical Toxicology|March 12, 2008
Preclinical safety and pharmacology of Hematide, a peptidic erythropoiesis stimulating agent (ESA), in rats and monkeysKathryn W Woodburn, Peter J Schatz, Kei-Lai Fong, et al.
Pageof 3